Quality headwinds

Oct 02, 2025

“If a business does well, the stock eventually follows.”

As the Sage of Omaha finally withdraws from the frontline of investing later this year, everyone has been keen to plunder his aphorisms, plentiful as they are. On the surface, the aforementioned quote is simple but, given space, it reveals many truths; not least about the long-term nature of investing (a painful experience for many seasoned fund managers) but also about the nature of investing philosophies and their interplay with markets.

It has been a particularly arduous period for quality investors in Europe of late, in no small part because Europe has started to attract global investor attention of a rare persistency, just as the style is in the doldrums. To clarify, it is not that investors have fallen out of love with an investment style that has performed admirably for decades. It is that on a relative basis to a market that has risen 18% since the post-Liberation Day lows, and 40% in three years, quality investors have lagged even when they have posted strong absolute returns. Another way of looking at the picture: over the last two years, the MSCI Europe Index has returned nearly 26.2%, the MSCI Europe Value Index has returned nearly 36.3%, and the MSCI Europe Quality Index has risen just 11.5%.1 Hardly the most accommodating of environments.

We have repeatedly written about our aversion to labels or buckets, and it would be incongruous of us to begin using them now while chafing at circumstance. So, a more appropriate starting point would be to set out Quality as a concept. There is no universal definition, but we would suggest that a quality company tends to display the following three elements: high and persistent cash generation, high and sustainable returns on capital, and the opportunity (either organically or otherwise) for growth. These are by no means the only elements, but at the very least they represent the overarching theme that dominates the kinds of businesses that often fall into this category. Apposite industries include pharmaceuticals, consumer names (both staples and discretionary), and certain areas of the semiconductor industry. As investors who operate on a fundamental, bottom-up basis searching for businesses that can generate high and sustainable levels of profitability and compound shareholder value over time, we are often led to these ‘quality’ areas, though this by no means precludes others.

Philosophically we have always believed that over the long term (i.e. at a minimum a full market cycle, and between five and ten years) these sorts of businesses should outperform the market given their ability to compound shareholder value over time, their ability to withstand stress and strain from economic and market gyrations, and the fact that their innate competitive advantages and persistent return profiles allows them to adapt and take advantage of existing and emerging secular trends. That said, no investment style can outperform at all times and the last 18 months have demonstrated that.

Style cycle frameworks are a useful tool for analysing what part of the business or economic cycle one may be in. Often separated into different segments, the cycle can broadly be split into four elements which reflect differing periods of economic growth and contraction. Using the Bank of America Merrill Lynch (BAML) Style Cycle Framework2 for example, these are labelled as Boom, Slowdown, Recession, and Recovery. Different asset classes and investment styles have historically outperformed during each different stage of the cycle which is to be expected given the feed-through to businesses from the broader economy. BAML’s framework currently suggests that we are in the Recovery stage of the cycle, a period where Value outperforms, as do low quality names, small caps and rising momentum names. This has been born out in markets of late as compressed risk premia, low unemployment, and high corporate profits, all combine for a risk-on environment where the demand for safety and quality is at a low. What is particularly interesting at the moment, however, is that this particular ‘Recovery’ stage has now been ongoing for 19 consecutive months, the longest on record.

However, at a sector level the devil remains – as always – in the detail. Pharmaceutical companies have faced idiosyncratic issues, stemming in part from the threats emanating from the Trump administration over pricing, resulting in a derating even though earnings and drug development pipelines are in a formidable position. Luxury goods businesses have suffered from a slowdown in China as well as a stellar run over the preceding decade. On the other side of the style ledger have been European defence stocks. The combination of a war on the border and the shakiness of the US guarantee to the bloc and NATO more broadly has meant the ramp up in defence spending commitments has resulted in extraordinary returns for the sector. Considering that this was one where most companies were sub-cost of capital only a few years ago, it is quite the turnaround.

Which leaves us at the following juncture: European quality stocks sit at a seven-year relative low, even after bond yields have fallen since the start of the year across many countries (quality stocks often move inversely to bond yields), and many are at historically low valuations. As investors, this presents a challenge: the age-old friction between adherence to an investment philosophy and riding the challenging performance periods and adapting to certain changes in the investing arena that may prove longer than expected. Or to put it another way, in case markets do remain irrational longer than you can stay solvent.

There are some suggestions that perhaps the underlying nature of businesses have changed to such an extent that quality is no longer what it once was. We are deeply sceptical of this idea especially given the points made earlier about the length of the current cycle. Some commentators now query whether all European banks are now quality investments in the longer term rather than just some of the more traditionally resilient and high-return businesses often found in the north of the continent. While we own many excellent banks across the bloc, we would always note that while cyclical, often leveraged businesses may look great during benign economic periods, the litmus test comes when economic headwinds emerge. In much the same way that concerns are prevalent over the private credit industry which has yet to experience a major macro downturn, we do not believe that companies can jettison their cyclicality so easily.

So, what to do in the face of such a stylistically unfavourable environment? The first is to exploit an investor’s skillset, namely fundamental bottom-up analysis. Does the investment case for each individual company still stack up? If so, a deeply unemotive analysis of a stock’s valuation is required to ascertain whether this is a buying opportunity, even when a company is out of favour. It is not a question as to whether these are excellent businesses. It is a question of disassociating a business from the market environment. The second is to reappraise all areas of the market to truly see if previously unattractive sectors from a philosophical perspective have indeed changed their spots, or whether they are merely masquerading. Finally, a rigorous use of risk tools that can help flatten style exposures relative to the market using both new and existing holdings can ensure that in periods where underperformance is likely, it is kept as small as possible.

Benjamin Graham once said that investing “isn’t about beating others at their game. It’s about controlling yourself at your own game.” In an investing arena that is contending with extraordinary levels of volatility both at a market and macro level, his words are more pertinent than ever.


1 Bloomberg, September 2025
2 Bank of America Merrill Lynch, 2025

Sign up for insights by email

Subscribe now to receive the latest investment and economic insights from our experts, sent straight to your inbox.

This document is a marketing communication and it may be produced and issued by the following entities: in the European Economic Area (EEA), by BlueBay Funds Management Company S.A. (BBFM S.A.), which is regulated by the Commission de Surveillance du Secteur Financier (CSSF). In Germany, Italy, Spain and Netherlands the BBFM S.A is operating under a branch passport pursuant to the Undertakings for Collective Investment in Transferable Securities Directive (2009/65/EC) and the Alternative Investment Fund Managers Directive (2011/61/EU). In the United Kingdom (UK) by RBC Global Asset Management (UK) Limited (RBC GAM UK), which is authorised and regulated by the UK Financial Conduct Authority (FCA), registered with the US Securities and Exchange Commission (SEC) and a member of the National Futures Association (NFA) as authorised by the US Commodity Futures Trading Commission (CFTC). In Switzerland, by BlueBay Asset Management AG where the Representative and Paying Agent is BNP Paribas Securities Services, Paris, succursale de Zurich, Selnaustrasse 16, 8002 Zurich, Switzerland. The place of performance is at the registered office of the Representative. The courts at the registered office of the Swiss representative or at the registered office or place of residence of the investor shall have jurisdiction pertaining to claims in connection with the offering and/or advertising of shares in Switzerland. The Prospectus, the Key Investor Information Documents (KIIDs), the Packaged Retail and Insurance-based Investment Products - Key Information Documents (PRIIPs KID), where applicable, the Articles of Incorporation and any other document required, such as the Annual and Semi-Annual Reports, may be obtained free of charge from the Representative in Switzerland. In Japan, by BlueBay Asset Management International Limited which is registered with the Kanto Local Finance Bureau of Ministry of Finance, Japan. In Asia, by RBC Global Asset Management (Asia) Limited, which is registered with the Securities and Futures Commission (SFC) in Hong Kong. In Australia, RBC GAM UK is exempt from the requirement to hold an Australian financial services license under the Corporations Act in respect of financial services as it is regulated by the FCA under the laws of the UK which differ from Australian laws. In Canada, by RBC Global Asset Management Inc. (including PH&N Institutional) which is regulated by each provincial and territorial securities commission with which it is registered. RBC GAM UK is not registered under securities laws and is relying on the international dealer exemption under applicable provincial securities legislation, which permits RBC GAM UK to carry out certain specified dealer activities for those Canadian residents that qualify as "a Canadian permitted client”, as such term is defined under applicable securities legislation. In the United States, by RBC Global Asset Management (U.S.) Inc. ("RBC GAM-US"), an SEC registered investment adviser. The entities noted above are collectively referred to as “RBC BlueBay” within this document. The registrations and memberships noted should not be interpreted as an endorsement or approval of RBC BlueBay by the respective licensing or registering authorities. Not all products, services or investments described herein are available in all jurisdictions and some are available on a limited basis only, due to local regulatory and legal requirements.

This document is intended only for “Professional Clients” and “Eligible Counterparties” (as defined by the Markets in Financial Instruments Directive (“MiFID”) or the FCA); or in Switzerland for “Qualified Investors”, as defined in Article 10 of the Swiss Collective Investment Schemes Act and its implementing ordinance, or in the US by “Accredited Investors” (as defined in the Securities Act of 1933) or “Qualified Purchasers” (as defined in the Investment Company Act of 1940) as applicable and should not be relied upon by any other category of customer.

Unless otherwise stated, all data has been sourced by RBC BlueBay. To the best of RBC BlueBay’s knowledge and belief this document is true and accurate at the date hereof. RBC BlueBay makes no express or implied warranties or representations with respect to the information contained in this document and hereby expressly disclaim all warranties of accuracy, completeness or fitness for a particular purpose. Opinions and estimates constitute our judgment and are subject to change without notice. RBC BlueBay does not provide investment or other advice and nothing in this document constitutes any advice, nor should be interpreted as such. This document does not constitute an offer to sell or the solicitation of an offer to purchase any security or investment product in any jurisdiction and is for information purposes only.

No part of this document may be reproduced, redistributed or passed on, directly or indirectly, to any other person or published, in whole or in part, for any purpose in any manner without the prior written permission of RBC BlueBay. Copyright 2025 © RBC BlueBay. RBC Global Asset Management (RBC GAM) is the asset management division of Royal Bank of Canada (RBC) which includes RBC Global Asset Management (U.S.) Inc. (RBC GAM-US), RBC Global Asset Management Inc., RBC Global Asset Management (UK) Limited and RBC Global Asset Management (Asia) Limited, which are separate, but affiliated corporate entities. ® / Registered trademark(s) of Royal Bank of Canada and BlueBay Asset Management (Services) Ltd. Used under licence. BlueBay Funds Management Company S.A., registered office 4, Boulevard Royal L-2449 Luxembourg, company registered in Luxembourg number B88445. RBC Global Asset Management (UK) Limited, registered office 100 Bishopsgate, London EC2N 4AA, registered in England and Wales number 03647343. All rights reserved. 

Sign up for insights by email

Subscribe now to receive the latest investment and economic insights from our experts, sent straight to your inbox.